The Charger Bulletin

FDA Reviews 2 New Drugs to Reduce Prostate Cancer

The Associated Press December 1, 2010

WASHINGTON – Health regulators said Monday that two drugs from GlaxoSmithKline and Merck reduce the risk of prostate cancer in men, though scientists questioned the drugs’ overall benefit, since the...

Load More Stories

Comments (0)

All The Charger Bulletin Picks Reader Picks Sort: Newest
Activate Search
The Student News Source of the University of New Haven